You are here

Article info

Article menu
Download PDFPDF
Basic and translational research
Extended report
IL-22 capacitates dermal fibroblast responses to TNF in scleroderma

Authors

  • Nicolò Costantino Brembilla Department of Immunology and Allergy, University Hospital and School of Medicine, Geneva, Switzerland Department of Dermatology, University Hospital and School of Medicine, Geneva, Switzerland Department of Pathology and Immunology, School of Medicine, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Aleksandra Maria Dufour Department of Immunology and Allergy, University Hospital and School of Medicine, Geneva, Switzerland Department of Pathology and Immunology, School of Medicine, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Montserrat Alvarez Department of Immunology and Allergy, University Hospital and School of Medicine, Geneva, Switzerland Department of Pathology and Immunology, School of Medicine, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Stéphanie Hugues Department of Pathology and Immunology, School of Medicine, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Elisa Montanari Department of Immunology and Allergy, University Hospital and School of Medicine, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Marie-Elise Truchetet Department of Immunology and Allergy, University Hospital and School of Medicine, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Paola Lonati Department of Immunology and Allergy, University Hospital and School of Medicine, Geneva, Switzerland Experimental Laboratory of Immunological and Rheumatologic Researches, IRCSS Istituto Auxologico Italiano, Milan, Italy PubMed articlesGoogle scholar articles
  • Lionel Fontao Department of Dermatology, University Hospital and School of Medicine, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Armando Gabrielli Department of Internal Medicine, Institute of Clinica Medica, Ancona, Italy PubMed articlesGoogle scholar articles
  • Serena Vettori Department of Rheumatology, Clinical and Experimental Medicine, Second University of Naples, Naples, Italy PubMed articlesGoogle scholar articles
  • Gabriele Valentini Department of Rheumatology, Clinical and Experimental Medicine, Second University of Naples, Naples, Italy PubMed articlesGoogle scholar articles
  • Wolf-Henning Boehncke Department of Dermatology, University Hospital and School of Medicine, Geneva, Switzerland Department of Pathology and Immunology, School of Medicine, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Pierluigi Meroni Experimental Laboratory of Immunological and Rheumatologic Researches, IRCSS Istituto Auxologico Italiano, Milan, Italy Division of Rheumatology, Istituto G Pini, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy PubMed articlesGoogle scholar articles
  • Carlo Chizzolini Department of Immunology and Allergy, University Hospital and School of Medicine, Geneva, Switzerland Department of Pathology and Immunology, School of Medicine, Geneva, Switzerland PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Carlo Chizzolini, Department of Immunology and Allergy, University Hospital, Rue Gabrielle Perret-Gentil 4, 1211 Geneva 14, Switzerland; carlo.chizzolini{at}unige.ch
View Full Text

Citation

Brembilla NC, Dufour AM, Alvarez M, et al
IL-22 capacitates dermal fibroblast responses to TNF in scleroderma
Annals of the Rheumatic Diseases 2016;75:1697-1705.

Publication history

  • Received February 17, 2015
  • Revised September 14, 2015
  • Accepted September 20, 2015
  • First published October 9, 2015.
Online issue publication 
October 31, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/